Overall, this research not only enriches our comprehension of SSc, offering potential therapeutic targets, but also expands our knowledge of the significance of the IFIT3/TBK1 signalling pathway in immune regulation and pathological processes. Here, IFIT3 is linked to systemic sclerosis.